Kentucky Retirement Systems Insurance Trust Fund decreased its stake in The Allstate Co. (NYSE:ALL – Free Report) by 8.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,818 shares of the insurance provider’s stock after selling 694 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Allstate were worth $1,483,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Northwest Investment Counselors LLC purchased a new stake in Allstate in the 3rd quarter worth approximately $28,000. Catalyst Capital Advisors LLC purchased a new stake in Allstate during the third quarter worth $29,000. Versant Capital Management Inc increased its holdings in Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after buying an additional 78 shares in the last quarter. Family Firm Inc. acquired a new position in shares of Allstate in the second quarter worth about $38,000. Finally, MCF Advisors LLC boosted its stake in shares of Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 84 shares in the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.
Allstate Stock Up 0.6 %
Shares of ALL opened at $196.88 on Friday. The Allstate Co. has a 52-week low of $131.65 and a 52-week high of $201.00. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The stock has a fifty day simple moving average of $190.01 and a two-hundred day simple moving average of $176.77. The company has a market capitalization of $52.13 billion, a PE ratio of 12.75, a price-to-earnings-growth ratio of 1.75 and a beta of 0.48.
Allstate Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be given a $0.92 dividend. The ex-dividend date is Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.87%. Allstate’s payout ratio is 23.83%.
Insiders Place Their Bets
In other Allstate news, EVP Robert Toohey sold 16,682 shares of Allstate stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the completion of the sale, the executive vice president now directly owns 4,873 shares in the company, valued at $877,968.41. This trade represents a 77.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares in the company, valued at approximately $5,236,922.32. This represents a 57.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 143,049 shares of company stock valued at $26,106,112 over the last quarter. 1.80% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on ALL. Wells Fargo & Company lifted their price target on Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 5th. Bank of America upped their target price on Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. UBS Group lifted their price target on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Keefe, Bruyette & Woods increased their price objective on shares of Allstate from $222.00 to $225.00 and gave the company an “outperform” rating in a report on Wednesday, November 6th. Finally, Roth Mkm reissued a “buy” rating and set a $200.00 target price on shares of Allstate in a research note on Wednesday, August 14th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Allstate presently has a consensus rating of “Moderate Buy” and a consensus price target of $214.19.
Read Our Latest Research Report on ALL
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- What is a Low P/E Ratio and What Does it Tell Investors?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What Are Dividend Contenders? Investing in Dividend Contenders
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How to Invest in Small Cap StocksĀ
- Time to Load Up on Home Builders?
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.